371 - Itolizumab, a Novel Targeted Anti-CD6 Therapy, Induces Cleavage of Cell Surface CD6 and Rapid Onset of Efficacy in Subjects with Newly Diagnosed Acute Graft-Versus-Host Disease

Autor: Ng, Cherie Tracy, Chinn, Leslie, Acevedo, Lisette M, Chu, Dalena, Fung, Maple, Rothman, Joel, Connelly, Stephen, Thomas, Dolca, Cutler, Corey, Koreth, John
Zdroj: In Transplantation and Cellular Therapy March 2022 28(3) Supplement:S287-S288
Databáze: ScienceDirect